SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Emergent BioSolutions Signs Contract with BARDA/NIAID, Valued at Up to $29.7 Million, to Fund Development of AV7909 - A Next Generation Anthrax Vaccine